Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.75M | 8.39M | 8.28M | 7.20M | 5.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.75M | 8.39M | 8.28M | 7.20M | 5.25M |
| Cost of Revenue | 5.56M | 6.04M | 6.53M | 5.94M | 4.09M |
| Gross Profit | 2.19M | 2.35M | 1.75M | 1.26M | 1.16M |
| SG&A Expenses | 2.05M | 2.32M | 1.98M | 2.01M | 2.23M |
| Depreciation & Amortization | 805.00K | 792.90K | 804.00K | 773.30K | 800.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.49M | 9.16M | 9.54M | 8.68M | 7.26M |
| Operating Income | -744.20K | -773.90K | -1.27M | -1.48M | -2.02M |
| Income Before Tax | -1.20M | -1.46M | -1.86M | -838.70K | -4.78M |
| Income Tax Expenses | 2.20K | -4.40K | 5.90K | 721.80K | -90.20K |
| Earnings from Continuing Operations | -1.21M | -1.46M | -1.87M | -1.56M | -4.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | -- |
| Net Income | -1.21M | -1.46M | -1.87M | -1.56M | -4.69M |
| EBIT | -744.20K | -773.90K | -1.27M | -1.48M | -2.02M |
| EBITDA | -552.80K | -585.40K | -1.07M | -1.42M | -1.17M |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 113.10M | 113.03M | 103.26M | 101.50M | 101.42M |
| Average Diluted Shares Outstanding | 113.10M | 113.03M | 103.26M | 101.50M | 101.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |